tiprankstipranks
Analyst Profile
Followed by 4 other investors
.
David Low

David Low

J.P. Morgan
Wall Street Analyst
Ranked #4,602 out of 8,019 Analysts on TipRanks (#10,779 out of 21,482 overall experts)

Success Rate

62%
16 out of 26 Profitable Transactions

Average Return

1.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied David Low's ratings since 2019 and opened each position for the duration of 1 Year:
61.54% of your transactions would have been profitable with an average return of 1.0%

Stock Rating Distribution

74Ratings
50.00% Hold
41.89% Buy
8.11% Sell
Distribution of David Low's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
AustraliaAustralian Market
GermanyGermany Market

Best Rating

Stock:
Resmed Inc
(RMD)
Rating Type:Buy
Dates:May 21, 2021 - Jul 28, 2021
Gain:31.60%
The most profitable rating made by David Low

David Low's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Hold
Downgraded
0.00%
1
Sonic Healthcare
Hold
Reiterated
100%
+20.00%
7
Japara Healthcare Limited
Hold
Reiterated
0.00%
1
Ramsay Health Care
Buy
Reiterated
$53.45
(11.41% Upside)
67%
-1.23%
3
Estia Health Ltd.
Hold
Reiterated
0.00%
1
Regis Healthcare Ltd.
Hold
Reiterated
A$2.30
(3.14% Upside)
0.00%
2
Nanosonics Limited
Sell
Reiterated
$2.49
(-25.32% Downside)
0%
-13.65%
4
Fisher & Paykel Healthcare Corporation Limited
Hold
Reiterated
$16.04
(15.78% Upside)
50%
+3.45%
10
Cochlear Limited
Hold
Reiterated
$155.36
(3.15% Upside)
0%
-6.80%
3
Buy
Reiterated
$224.49
(8.87% Upside)
75%
+1.80%
7
List of latest recommendations made by David Low. Click to expand and see David Low's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More